{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:53:41Z","timestamp":1791478421450,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2017\/004385"],"award-info":[{"award-number":["EMR\/2017\/004385"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10014-022-00429-2","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T10:13:18Z","timestamp":1648548798000},"page":"151-161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Molecular subgrouping of ependymoma across three anatomic sites and their prognostic implications"],"prefix":"10.1007","volume":"39","author":[{"given":"Dheeraj","family":"Chinnam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9999-3203","authenticated-orcid":false,"given":"Kirti","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvi","family":"Kiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aastha","family":"Saraswati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin","family":"Salunke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishan Dass","family":"Radotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,29]]},"reference":[{"key":"429_CR1","first-page":"101","volume-title":"WHO classification of tumours of the central nervous system","author":"DW Ellison","year":"2016","unstructured":"Ellison DW, McLendon R, Wiestler OD et al (2016) Ependymal tumors. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A, Reifenberger G, von Deimling A (eds) WHO classification of tumours of the central nervous system, 4th edn. International Agency for Research on Cancer, Lyon, pp 101\u2013114","edition":"4"},{"key":"429_CR2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3171\/2008.9.JNS08117","volume":"110","author":"CS McGuire","year":"2009","unstructured":"McGuire CS, Sainani KL, Fisher PG (2009) Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study. J Neurosurg 110:725\u2013729","journal-title":"J Neurosurg"},{"key":"429_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1477-5751-10-7","volume":"10","author":"DW Ellison","year":"2011","unstructured":"Ellison DW, Kocak M, Figarella-Branger D et al (2011) Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed 10:7","journal-title":"J Negat Results Biomed"},{"key":"429_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/modpathol.3800999","volume":"21","author":"T Tihan","year":"2008","unstructured":"Tihan T, Zhou T, Holmes E et al (2008) The prognostic value of histological grading of posterior fossa ependymomas in children: a Children\u2019s Oncology Group study and a review of prognostic factors. Mod Pathol 21:165\u2013177","journal-title":"Mod Pathol"},{"issue":"1","key":"429_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12035-015-9646-8","volume":"54","author":"K Gupta","year":"2017","unstructured":"Gupta K, Salunke P (2017) Understanding ependymoma oncogenesis: an update on recent molecular advances and current perspectives. Mol Neurobiol 54(1):15\u201321","journal-title":"Mol Neurobiol"},{"issue":"5","key":"429_CR6","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","volume":"27","author":"KW Pajtler","year":"2015","unstructured":"Pajtler KW, Witt H, Sill M et al (2015) Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 27(5):728\u2013743","journal-title":"Cancer Cell"},{"key":"429_CR7","unstructured":"Ellison DW (2022) Ependymoma. In: WHO classification of tumours editorial board. World Health Organization classification of tumours of the central nervous system. 5th edn. International Agency for Research on Cancer press, Lyon, pp 159\u2013176"},{"issue":"7489","key":"429_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature13109","volume":"506","author":"M Parker","year":"2014","unstructured":"Parker M, Mohankumar KM, Punchihewa C et al (2014) C11orf95-RELA fusions drive oncogenic NF-\u03baB signalling in ependymoma. Nature 506(7489):451\u2013455","journal-title":"Nature"},{"issue":"4","key":"429_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00401-014-1264-4","volume":"127","author":"T Pietsch","year":"2014","unstructured":"Pietsch T, Wohlers I, Goschzik T et al (2014) Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to pathological activation of the NF-\u03baB signaling pathway. Acta Neuropathol 127(4):609\u2013611","journal-title":"Acta Neuropathol"},{"issue":"5","key":"429_CR10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/bpa.12866","volume":"30","author":"DW Ellison","year":"2020","unstructured":"Ellison DW, Aldape KD, Capper D et al (2020) cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors. Brain Pathol 30(5):863\u2013866","journal-title":"Brain Pathol"},{"issue":"2","key":"429_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/bpa.12659","volume":"29","author":"F Andreiuolo","year":"2019","unstructured":"Andreiuolo F, Varlet P, Tauzi\u00e8de-Espariat A et al (2019) Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features. Brain Pathol 29(2):205\u2013216","journal-title":"Brain Pathol"},{"issue":"1","key":"429_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41379-019-0329-2","volume":"33","author":"M Torre","year":"2020","unstructured":"Torre M, Alexandrescu S, Dubuc AM et al (2020) Characterization of molecular signatures of supratentorial ependymomas. Mod Pathol 33(1):47\u201356","journal-title":"Mod Pathol"},{"issue":"1","key":"429_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11060-018-2767-y","volume":"138","author":"PB Malgulwar","year":"2018","unstructured":"Malgulwar PB, Nambirajan A, Pathak P et al (2018) C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin. J Neurooncol 138(1):29\u201339","journal-title":"J Neurooncol"},{"issue":"1","key":"429_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/PAS.0000000000000979","volume":"43","author":"M Gessi","year":"2019","unstructured":"Gessi M, Giagnacovo M, Modena P et al (2019) Role of immunohistochemistry in the identification of supratentorial C11ORF95-RELA fused ependymoma in routine neuropathology. Am J Surg Pathol 43(1):56\u201363","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"429_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s10014-019-00338-x","volume":"36","author":"A Sasaki","year":"2019","unstructured":"Sasaki A, Hirato J, Hirose T et al (2019) Review of ependymomas: assessment of consensus in pathological diagnosis and correlations with genetic profiles and outcome. Brain Tumor Pathol 36(2):92\u2013101","journal-title":"Brain Tumor Pathol"},{"issue":"3","key":"429_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/bpa.12664","volume":"29","author":"M Pag\u00e8s","year":"2019","unstructured":"Pag\u00e8s M, Pajtler KW, Puget S et al (2019) Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging. Brain Pathol 29(3):325\u2013335","journal-title":"Brain Pathol"},{"issue":"12","key":"429_CR17","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1200\/JCO.18.01765","volume":"37","author":"TE Merchant","year":"2019","unstructured":"Merchant TE, Bendel AE, Sabin ND et al (2019) Conformal radiation therapy for pediatric ependymoma, chemotherapy for incompletely resected ependymoma, and observation for completely resected, supratentorial ependymoma. J Clin Oncol 37(12):974\u2013983","journal-title":"J Clin Oncol"},{"issue":"1","key":"429_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s40478-018-0630-1","volume":"6","author":"K Fukuoka","year":"2018","unstructured":"Fukuoka K, Kanemura Y, Shofuda T et al (2018) Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors. Acta Neuropathol Commun 6(1):134","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"429_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ccr.2011.07.007","volume":"20","author":"H Witt","year":"2011","unstructured":"Witt H, Mack SC, Ryzhova M et al (2011) Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 20(2):143\u2013157","journal-title":"Cancer Cell"},{"issue":"5","key":"429_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00401-017-1752-4","volume":"134","author":"P Panwalkar","year":"2017","unstructured":"Panwalkar P, Clark J, Ramaswamy V et al (2017) Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome. Acta Neuropathol 134(5):705\u2013714","journal-title":"Acta Neuropathol"},{"issue":"1","key":"429_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10014-021-00417-y","volume":"39","author":"KY Lim","year":"2022","unstructured":"Lim KY, Lee K, Shim Y et al (2022) Molecular subtyping of ependymoma and prognostic impact of Ki-67. Brain Tumor Pathol 39(1):1\u201313","journal-title":"Brain Tumor Pathol"},{"issue":"6","key":"429_CR22","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00401-019-02056-2","volume":"138","author":"DR Ghasemi","year":"2019","unstructured":"Ghasemi DR, Sill M, Okonechnikov K et al (2019) MYCN amplification drives an aggressive form of spinal ependymoma. Acta Neuropathol 138(6):1075\u20131089","journal-title":"Acta Neuropathol"},{"issue":"3","key":"429_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/1066896918800812","volume":"27","author":"P Chavali","year":"2019","unstructured":"Chavali P, Rao S, Palavalasa S et al (2019) L1CAM immunopositivity in anaplastic supratentorial ependymomas: correlation with clinical and histological parameters. Int J Surg Pathol 27(3):251\u2013258","journal-title":"Int J Surg Pathol"},{"issue":"suppl 5","key":"429_CR24","doi-asserted-by":"publisher","first-page":"v30","DOI":"10.1093\/neuonc\/nou239.30","volume":"16","author":"K Wani","year":"2014","unstructured":"Wani K, Armstrong TS, Jones DT et al (2014) Characterization of L1CAM as a clinical marker for the C11orf95-RELA fusion in supratentorial ependymomas. Neuro Oncol 16(suppl 5):v30\u2013v30","journal-title":"Neuro Oncol"},{"key":"429_CR25","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/neuonc\/now025","volume":"18","author":"D Figarella-Branger","year":"2016","unstructured":"Figarella-Branger D, Lechapt-Zalcman E, Tabouret E et al (2016) Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling. Neuro Oncol 18:919\u2013927","journal-title":"Neuro Oncol"},{"issue":"12","key":"429_CR26","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1097\/PAS.0000000000001342","volume":"43","author":"L Wang","year":"2019","unstructured":"Wang L, Liu L, Li H et al (2019) RELA fusion in supratentorial extraventricular ependymomas: a morphologic, immunohistochemical, and molecular study of 43 cases. Am J Surg Pathol 43(12):1674\u20131681","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"429_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00401-020-02260-5","volume":"141","author":"V Zschernack","year":"2021","unstructured":"Zschernack V, J\u00fcnger ST, Mynarek M et al (2021) Supratentorial ependymoma in childhood: more than just RELA or YAP. Acta Neuropathol 141(3):455\u2013466","journal-title":"Acta Neuropathol"},{"issue":"1","key":"429_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s40478-021-01238-y","volume":"9","author":"A Tauzi\u00e8de-Espariat","year":"2021","unstructured":"Tauzi\u00e8de-Espariat A, Siegfried A, Nicaise Y et al (2021) Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1\/2 fusions. Acta Neuropathol Commun 9(1):135","journal-title":"Acta Neuropathol Commun"},{"issue":"10","key":"429_CR29","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/neuonc\/noz069","volume":"21","author":"SA Upadhyaya","year":"2019","unstructured":"Upadhyaya SA, Robinson GW, Onar-Thomas A et al (2019) Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial. Neuro Oncol 21(10):1319\u20131330","journal-title":"Neuro Oncol"},{"issue":"6","key":"429_CR30","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.molcel.2020.05.020","volume":"78","author":"GL Lin","year":"2020","unstructured":"Lin GL, Monje M (2020) Understanding the deadly silence of posterior fossa A ependymoma. Mol Cell 78(6):999\u20131001","journal-title":"Mol Cell"},{"issue":"7489","key":"429_CR31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature13108","volume":"506","author":"SC Mack","year":"2014","unstructured":"Mack SC, Witt H, Piro RM et al (2014) Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature 506(7489):445\u2013450","journal-title":"Nature"},{"issue":"1","key":"429_CR32","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1038\/s41467-019-09981-6","volume":"10","author":"SU Jain","year":"2019","unstructured":"Jain SU, Do TJ, Lund PJ et al (2019) PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism. Nat Commun 10(1):2146","journal-title":"Nat Commun"},{"issue":"6","key":"429_CR33","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.cell.2020.04.047","volume":"181","author":"KA Michealraj","year":"2020","unstructured":"Michealraj KA, Kumar SA, Kim LJY et al (2020) Metabolic regulation of the epigenome drives lethal infantile ependymoma. Cell 181(6):1329\u20131345","journal-title":"Cell"},{"issue":"4","key":"429_CR34","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00401-016-1608-3","volume":"132","author":"M Gessi","year":"2016","unstructured":"Gessi M, Capper D, Sahm F et al (2016) Evidence of H3 K27M mutations in posterior fossa ependymomas. Acta Neuropathol 132(4):635\u2013637","journal-title":"Acta Neuropathol"},{"issue":"2","key":"429_CR35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00401-018-1877-0","volume":"136","author":"KW Pajtler","year":"2018","unstructured":"Pajtler KW, Wen J, Sill M et al (2018) Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas. Acta Neuropathol 136(2):211\u2013226","journal-title":"Acta Neuropathol"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-022-00429-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10014-022-00429-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-022-00429-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T06:05:29Z","timestamp":1700373929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10014-022-00429-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,29]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["429"],"URL":"https:\/\/doi.org\/10.1007\/s10014-022-00429-2","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,29]]},"assertion":[{"value":"30 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was in accordance with the ethical standards of the institutional research committee and was approved by the same. The study conforms to the Declaration of Helsinki\u2019s ethical principles. Written informed consent was acquired from all human subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}